HB 935 amends Louisiana's TOPS scholarship program to allow students who complete undergraduate degrees early (in under eight semesters) to continue receiving full scholarship benefits for graduate medical sciences programs. It applies only to nonpublic colleges or universities that meet four specific criteria: offering graduate medical sciences programs, being physically collocated with a public university since 2020, billing tuition through that public institution, and not being part of Louisiana's independent colleges association. Students must maintain academic standards to retain the award. This policy change expands TOPS coverage to graduate medical education at qualifying institutions without altering the core scholarship structure.
HB 742 removes a requirement that applicants for the Family Independence Temporary Assistance Program and Medicaid must have certain immunizations. The bill repeals specific sections of Louisiana law (R.S. 46:231.4 and Section 13 of Act No. 478) that previously mandated these vaccinations for program eligibility. It directs the Department of Children and Family Services and the Louisiana Department of Health to update their rules to align with this change. This policy change directly affects individuals applying for these two public assistance programs by eliminating a vaccination prerequisite.
SB 242 amends Louisiana law to clarify definitions and requirements for home health agency licensure under the Louisiana Department of Health. It defines "home health aide services" as semi-skilled assistance with at least two daily living tasks, vital sign monitoring, and written reporting to healthcare professionals. The bill requires home health agencies to disclose any financial or familial ties to other home health providers when applying for or renewing their license. This directly affects home health agencies operating in Louisiana, mandating clearer service standards and transparency in ownership relationships. The bill is currently pending review by the Health and Welfare Committee.
SB 310, the "Signs of Hope Act," requires all public high school and college/university student health centers in Louisiana to display specific signs about pregnancy resources. The signs must read "Pregnant? Help Is Available for You and Your Baby!" with a website link to Louisiana Department of Health pregnancy resources, measure at least 16x20 inches, use large readable text, and include color graphics. These signs must be placed in patient admission areas, waiting rooms, and consultation rooms by health center staff. The Louisiana Department of Health designs the signs but may accept donated signs or use donated funds to cover costs, without requiring state funds.
HB 475 requires healthcare providers in Louisiana to obtain a patient's verbal consent before using artificial intelligence to transcribe medical appointments or treatments. If a patient declines consent, providers must conduct the appointment without AI transcription. This bill directly affects licensed healthcare professionals and their patients by establishing a clear consent process for AI-assisted documentation. The key provision mandates that providers cannot use AI transcription tools without explicit patient agreement, with an opt-out option ensuring no forced use of the technology. The legislation focuses solely on the consent requirement for AI transcription, not general recording practices.
HB 291 prevents health insurers in Louisiana from penalizing hospitals or clinics (participating healthcare facilities) solely because another provider at that facility - like a doctor or specialist - is dropped from the insurer's network. The bill directly affects healthcare facilities that coordinate patient care with multiple providers, ensuring they won’t face payment cuts or contract terminations due to a partner provider’s network status. Key provisions ban insurers from reducing payments or ending agreements with facilities based on another provider’s network exclusion, and require that any contract clauses attempting to override this rule are void. This policy change aims to stabilize provider relationships and care continuity for patients.
HB 766 requires health insurers in Louisiana to cover orally administered anti-cancer medications on the same terms as intravenously administered ones. It prohibits insurers from imposing higher copays, deductibles, or prior authorizations for oral medications compared to IV treatments, and bans programs that ignore drug discounts (like "accumulator" programs). The bill caps out-of-pocket costs for oral anti-cancer drugs at $100 per prescription and ensures cost-sharing counts toward annual out-of-pocket maximums. It applies to most health plans but excludes limited-benefit policies, high-deductible plans with HSAs, and self-funded ERISA plans. This directly affects cancer patients and insurers by reducing financial barriers to oral medication access.
SB 255 requires Medicaid-funded behavioral health providers in Louisiana to ensure staff delivering psychosocial rehabilitation (PSR) services hold at least a bachelor's degree in specific fields like counseling, social work, or psychology. This affects all licensed providers seeking Medicaid reimbursement for PSR services. The bill mandates these educational qualifications as a condition for continued reimbursement, updating existing Medicaid eligibility rules. The measure is pending legislative review and would not take effect until enacted.
SB 236 requires the Louisiana Department of Health to annually review Medicaid coverage for medications and treatments for chronic and rare kidney diseases, ensuring they meet patient needs. It mandates public input during these reviews and directs the department to partner with kidney disease organizations to boost education and early screening. The bill also requires an annual report to the legislature by January 15 each year, detailing review findings and recommendations. This affects Medicaid enrollees diagnosed with kidney disease in Louisiana by improving access to appropriate care and promoting early detection. The law focuses on systematic reviews and transparency, not changing Medicaid eligibility or funding.
SB 169 requires health insurance plans in Louisiana to cover biomarker testing for patients needing personalized medical treatment, such as cancer care guided by genetic markers. It defines "clinical utility" through specific criteria to ensure tests are covered without unnecessary hurdles. The law prevents insurers from denying coverage based on laboratory classifications or unrelated credentialing, ensuring the test itself - not the lab - is the focus of coverage. This directly affects patients seeking biomarker tests and insurers, reducing the need for repeated biopsies by mandating seamless coverage.
